Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zai Lab Limited - American Depositary Shares (NQ:ZLAB)

33.34 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zai Lab Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Why Yext Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting the day off right with a breakdown of the biggest pre-market stock movers worth reading about on Wednesday! 
Via InvestorPlace
Zai Lab: Q1 Earnings Insights
 
Via Benzinga
Earnings Preview For Zai Lab
 
Via Benzinga
Calavo Growers, Mondee Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Zai Lab Limited and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Novocure's Cancer Treating Electric Fields Improves Survival In Lung Cancer Patients, But Stock Tumbles On Remaining Doubts
 
Via Benzinga
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
From Zai Lab Limited
Via GlobeNewswire
FDA's AdComm Panel Favors Innoviva's Drug For Multidrug-Resistant Bacterial Infections
 
Via Benzinga
Zscaler, MongoDB, Chemours And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining over 400 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Zai Lab to Highlight New Data from its Oncology Pipeline at 2023 ASCO Annual Meeting
From Zai Lab Limited
Via GlobeNewswire
Intel, Noah Holdings, Twilio And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. SunCar Technology Group Inc. (NASDAQ: SDA) shares gained... 
Via Benzinga
Zai Lab Announces Participation in June Investor Conferences
From Zai Lab Limited
Via GlobeNewswire
Why Shares of Alibaba, PDD, and Zai Lab Are Rising Today
Several Chinese stocks rose today after positive sentiment from Wall Street and recent comments made by President Biden. 
Via The Motley Fool
Zai Lab Announces That Repotrectinib Granted Priority Review by China’s NMPA
From Zai Lab Limited
Via GlobeNewswire
Zai Lab Announces First Quarter 2023 Financial Results and Corporate Updates
From Zai Lab Limited
Via GlobeNewswire
Earnings Scheduled For May 9, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.17 per share on revenue of $440.16 million. 
Via Benzinga
Zai Lab Announces Strategic Partnership and Global License Agreement with MediLink Therapeutics for a Next Generation Antibody-Drug Conjugate Program in Oncology
YL212 expands Zai Lab’s lung cancer franchise and enriches its global oncology pipeline with a potential first-in-class ADC 
From Zai Lab Limited
Via GlobeNewswire
Zai Lab Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
From Zai Lab Limited
Via GlobeNewswire
Zai Lab to Announce First Quarter 2023 Financial Results and Corporate Updates on May 9, 2023
Company to Host Conference Call and Webcast on May 10, 2023, at 8:00 a.m. ET 
From Zai Lab Limited
Via GlobeNewswire
Zai Lab to Highlight New Data from its Oncology Portfolio at 2023 AACR Annual Meeting
New translational and clinical biomarker data from Zai Lab’s global oncology program ZL-1211 will be featured in a poster presentation (Abstract presentation number: 4531) 
From Zai Lab Limited
Via GlobeNewswire
1 Hot Growth Stock to Buy Hand Over Fist Before It Blasts Off
This company plans to be profitable soon, and its revenue is already spiking. 
Via The Motley Fool
Zai Lab Partner Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-3 Trial of KarXT in Schizophrenia
From Zai Lab Limited
Via GlobeNewswire
2 Unmatched Stocks Wall Street Thinks Will Soar 152% or More in the Next 2 Years
Biotechs are capable of making huge gains in short periods, and they often do. 
Via The Motley Fool
Silicon Valley Bank Collapse Might Have Limited Impact On Asia, But Confidence Seems Shaken
Some Asian firms have disclosed cash deposits at troubled U.S. lender Silicon Valley Bank (NASDAQ: SIVB), known for its deep ties with the healthcare and tech sector. Most emphasized that the amounts... 
Via Benzinga
2 Stocks That Could Rebound and Rise 30% or More in 2023
They're down, but they aren't yet out. 
Via The Motley Fool
Why Shares of MacroGenics Jumped Thursday
The company made a sale worth as much as $200 million for the royalty rights for its type-1 diabetes therapy. 
Via The Motley Fool
2 Growth Stocks With Incredible Potential in the Next 5 Years
Neither is profitable, but both could be on the verge of massive booms in revenue. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.